Centre for Heart Lung Innovation, St. Paul's Hospital-University of British Columbia, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Rev Med Virol. 2024 Nov;34(6):e2586. doi: 10.1002/rmv.2586.
Viral myocarditis, characterised by inflammation of the heart muscle, presents a significant challenge to global public health, particularly affecting younger individuals and often progressing to dilated cardiomyopathy (DCM), a leading cause of heart failure. Despite ongoing research efforts, viable treatments for this condition remain elusive. Recent studies have shed light on the complex interplay between the innate immune response and autophagy mechanisms, revealing their pivotal roles in the pathogenesis of viral myocarditis and subsequent DCM development. This review aims to delve into the recent advancements in understanding the molecular mechanisms and pathways that intersect innate immunity and autophagy in the context of viral myocarditis. Furthermore, it explores the potential therapeutic implications of these findings, offering insights into promising avenues for the management and treatment of this debilitating condition.
病毒性心肌炎的特征是心肌炎症,对全球公共健康构成重大挑战,尤其影响年轻人,且常进展为扩张型心肌病(DCM),是心力衰竭的主要病因。尽管研究工作在持续进行,但这种疾病仍然缺乏可行的治疗方法。最近的研究揭示了固有免疫反应和自噬机制之间的复杂相互作用,阐明了它们在病毒性心肌炎发病机制和随后的 DCM 发展中的关键作用。本综述旨在深入探讨理解分子机制和途径的最新进展,这些机制和途径在病毒性心肌炎的背景下涉及固有免疫和自噬的相互作用。此外,还探讨了这些发现的潜在治疗意义,为管理和治疗这种使人虚弱的疾病提供了有希望的途径。